Brief: Sygnis signs non-exclusive distribution agreement with Cambridge Bioscience Ltd
04/05/2015 07:00
May 4 (Reuters) - Sygnis AG LIO1k.DE :
* Signs non-exclusive distribution agreement with Cambridge
Bioscience Ltd. for UK and Ireland
* Under terms of agreement, Cambridge Bioscience will
promote, market, sell and support TruePrime products for
primer-free WGA as well as SunScript thermostable reverse
transcriptase kits
Source text for Eikon: ID:nEQ6Lm9xfa
Further company coverage: LIO1k.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on 2Invest AG
See all newsBrief: sygnis Q1 revenues up 19 pct to 76,000 euros
Brief: Sygnis signs non-exclusive distribution agreement with Cambridge Bioscience Ltd
Brief: Sygnis FY 2014 operating loss reduced to 3.2 mln euros
Brief: Sygnis announces global launch of SunScript Reverse Transcriptase
Brief: Sygnis signs non-exclusive distribution agreement with Sopachem